Protagonist Therapeutics, Inc. (PTGX) by event type
PTGX moves most on analyst upgrades — a median of -0.72% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the PTGX overview →
How PTGX reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,507 of 2,717 | 15 | -0.72% | 33% | -0.97% |
| Coverage initiations 682 of 2,283 | 27 | +0.23% | 52% | -0.69% |
| Rating reiterations 1,376 of 3,522 | 118 | +0.03% | 51% | +0.40% |
| Price-target raises 977 of 1,790 | 33 | -0.01% | 49% | +0.94% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how PTGX usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · PTGX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cardinal Health, Inc. (CAH) | 335 | +0.02% | 52% |
| MannKind Corporation (MNKD) | 335 | -0.25% | 43% |
| MYOS RENS TECH INC COMMON (MYOS) | 334 | 0.00% | 43% |
| Actelis Networks, Inc. (ASNS) | 331 | -0.83% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.